Yoichiro Ogama

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of <scp>TAK</scp>‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

Helen Jenkins, Yuichi Sakurai, Akira Nishimura et al. · Alimentary Pharmacology & Therapeutics · 2015 · 307 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.

Takashi Oka, Mamoru Ouchida, Maho Koyama et al. · PubMed · 2002 · 211 citations

Life Sciences, Genetics, Oncology +17

Loss or down‐regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts

Kozo Masuda, Akio Hiraki, Nobuharu Fujii et al. · Cancer Science · 2006 · 62 citations · Full text

Life Sciences, Hematology, Immunology +17

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects

Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama et al. · Drug Research · 2017 · 40 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14

Effect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers

Kaori Morimoto, Kozue Kishimura, Takaaki Nagami et al. · Journal of Pharmaceutical Sciences · 2011 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12